search
Back to results

Very Early Surfactant and NCPAP for Premature Infants With RDS (CNRNCPAP)

Primary Purpose

Respiratory Distress Syndrome, Pneumothorax/Pulmonary Intersticial Emphysema, Chronic Lung Disease

Status
Completed
Phase
Phase 3
Locations
Colombia
Study Type
Interventional
Intervention
Very early surfactant and bubble NCPAP
bubble NCPAP
Sponsored by
Colombian Neonatal Research Network
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Distress Syndrome focused on measuring NCPAP, Very early surfactant

Eligibility Criteria

27 Weeks - 31 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Gestational age of 27 to 31 6/7 weeks,
  • Postnatal age between 15 and 60 minutes,
  • Supplemental oxygen requirement or evidence of increased work of breathing (tachypnea, intercostal retractions, nasal flaring, or grunting), and
  • Prenatal consent.

Exclusion Criteria:

  • Apgar score less than 2 at 5 minutes,
  • Intubation prior to randomization,
  • Prenatal diagnosis of major congenital anomalies,
  • Prolonged rupture of membranes of greater than 3 weeks duration, and
  • Infants who were likely to be transferred to another center soon after birth were not enrolled in the study.

Sites / Locations

  • Department of Epidemiology and Biostatistics Pontificia Universidad Javeriana

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

1

2

Arm Description

Early NCPAP plus very early surfactant

NCPAP alone

Outcomes

Primary Outcome Measures

Need for mechanical ventilation

Secondary Outcome Measures

Neonatal mortality
Air leak syndrome
Oxygen dependency at 36 weeks post menstrual age

Full Information

First Posted
November 23, 2007
Last Updated
November 23, 2007
Sponsor
Colombian Neonatal Research Network
Collaborators
Pontificia Universidad Javeriana, Vanderbilt University School of Medicine, Abbott, Fisher and Paykel Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT00563641
Brief Title
Very Early Surfactant and NCPAP for Premature Infants With RDS
Acronym
CNRNCPAP
Official Title
Very Early Surfactant Without Mandatory Ventilation In Premature Infants Treated With Early Continuous Positive Airway Pressure-A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2007
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Colombian Neonatal Research Network
Collaborators
Pontificia Universidad Javeriana, Vanderbilt University School of Medicine, Abbott, Fisher and Paykel Healthcare

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The present study will test the use of very early nasal continuous airway pressure(NCPAP)with and without surfactant in premature infants with clinical evidence or respiratory distress syndrome. We hypothesize that premature infants exposed to very early NCPAP and surfactant will require less mechanical ventilation compared to those premature infants exposed to NCPAP alone.
Detailed Description
Premature infants who are not intubated during the first 15 minutes of life and who develop clinical evidence of respiratory distress or need for oxygen requirement between 15 and 60 minutes of life, will be placed on bubble NCPAP of 6 cm H2O. Randomization envelops will them be opened and patients will be assigned to continuation on NCPAP alone (Control Group) or to NCPAP plus very early surfactant therapy (Treatment Group). Patients assigned to the treatment group will be transiently intubated for surfactant administration, extubated, and placed back on NCPAP of 6 cm H2O. Both groups will then be followed over time to determine which infants meet treatment failure criteria defined as: Treatment failure was defined a priori by either failure of adequate oxygenation or ventilation as follows: "1" FiO2 greater than 0.75 for more than 30 minutes to maintain SpO2 within the pre-established target ranges, "2" persistent or recurrent desaturation below 80% that did not respond to suctioning of the airways and PPV, "3" PCO2>65 mmHg and pH<7.22 on an arterial or capillary blood gas analysis, in association with increased work of breathing. Infants in the Treatment Group who cannot be extubated after their initial dose of surfactant because of clinical instability will be analyzed as treatment failures. Premature infants that meet treatment failure criteria on either arm will be intubated and placed on mechanical ventilation and given surfactant rescue doses according to the criteria of the participating institutions. Premature infants with respiratory distress syndrome who do not meet treatment failure criteria in both groups will remain on NCPAP until their respiratory failure improves.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome, Pneumothorax/Pulmonary Intersticial Emphysema, Chronic Lung Disease
Keywords
NCPAP, Very early surfactant

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
278 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Early NCPAP plus very early surfactant
Arm Title
2
Arm Type
Active Comparator
Arm Description
NCPAP alone
Intervention Type
Other
Intervention Name(s)
Very early surfactant and bubble NCPAP
Intervention Description
For patients randomized to early NCPAP plus surfactant, 4ml/kg of surfactant were administered through an endotracheal tube in two aliquots, 2 minutes apart followed by positive pressure ventilation administered for one minute with a Neopuff Infant Resuscitator pre-set to give a peak pressure of 20 cm H2O and 5 cm H2O of positive end expiratory pressure. Infant was then extubated and placed on NCPAP of 6 cmH2O
Intervention Type
Other
Intervention Name(s)
bubble NCPAP
Intervention Description
Premature infants randomized to bubble NCPAP alone will continue on NCPAP until they reach "yes or no" treatment failure criteria.
Primary Outcome Measure Information:
Title
Need for mechanical ventilation
Time Frame
Death or discharge from the NICU
Secondary Outcome Measure Information:
Title
Neonatal mortality
Time Frame
During hospitalization in the NICU
Title
Air leak syndrome
Time Frame
death or discharge from the NICU
Title
Oxygen dependency at 36 weeks post menstrual age
Time Frame
Death or discharge from the NICU

10. Eligibility

Sex
All
Minimum Age & Unit of Time
27 Weeks
Maximum Age & Unit of Time
31 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Gestational age of 27 to 31 6/7 weeks, Postnatal age between 15 and 60 minutes, Supplemental oxygen requirement or evidence of increased work of breathing (tachypnea, intercostal retractions, nasal flaring, or grunting), and Prenatal consent. Exclusion Criteria: Apgar score less than 2 at 5 minutes, Intubation prior to randomization, Prenatal diagnosis of major congenital anomalies, Prolonged rupture of membranes of greater than 3 weeks duration, and Infants who were likely to be transferred to another center soon after birth were not enrolled in the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mario A Rojas, MD, MPH
Organizational Affiliation
Vanderbilt University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Epidemiology and Biostatistics Pontificia Universidad Javeriana
City
Bogota
State/Province
Cundinamarca
Country
Colombia

12. IPD Sharing Statement

Citations:
PubMed Identifier
17882265
Citation
Rojas MA, Lozano JM, Rojas MX; Colombian Neonatal Research Network. International collaborative research: a Colombian model that promotes infant health and research capacity. J Perinatol. 2007 Dec;27(12):738-43. doi: 10.1038/sj.jp.7211827. Epub 2007 Sep 20. Erratum In: J Perinatol. 2007 Dec;27(12):808.
Results Reference
background
PubMed Identifier
19117872
Citation
Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, Charry L, Bastidas JA, Perez LA, Rojas C, Ovalle O, Celis LA, Garcia-Harker J, Jaramillo ML; Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics. 2009 Jan;123(1):137-42. doi: 10.1542/peds.2007-3501.
Results Reference
derived
Links:
URL
http://sparta.javeriana.edu.co/portal/principal/index.jsp
Description
website for Pontificia Universidad Javeriana Research

Learn more about this trial

Very Early Surfactant and NCPAP for Premature Infants With RDS

We'll reach out to this number within 24 hrs